“Altered Threonine Tyrosine Kinase (TTK) Expression Is Associated With Adverse Clinical Outcomes in Breast Tumors: An in Silico Approach”. 2023. Research, Society and Development 12 (13): e40121344285. https://doi.org/10.33448/rsd-v12i13.44285.